Medpace Holdings, Inc.
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and develā¦ read more
Healthcare
Diagnostics & Research
10 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$590.30
Price-1.14%
-$6.82
1Y
Price
Market Cap
$16.476b
Large
Price/Earnings 3y Avg5y Avg
34.6x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+18.9%
EBITDA Margin+17.2%
Net Profit Margin+19.5%
Free Cash Flow Margin+18.9%
EBITDA Margin+17.2%
Net Profit Margin+19.5%
Free Cash Flow MarginRevenue
$2.782b
+10.0%
1y CAGR+13.9%
3y CAGR+17.7%
5y CAGREarnings
$491.500m
+9.0%
1y CAGR+21.2%
3y CAGR+19.7%
5y CAGREPS
$17.07
+11.7%
1y CAGR+25.0%
3y CAGR+24.2%
5y CAGRBook Value
$433.861m
$2.057b
Assets$1.623b
Liabilities$120.100m
DebtDebt to Assets
5.8%
0.2x
Debt to EBITDAFree Cash Flow
$733.506m
+7.6%
1y CAGR+23.7%
3y CAGR+21.0%
5y CAGRNo items found.
Press Releases
Statements and updates from the company